Natco Pharma Q3 Results: Net profit declines 38% to ₹132.4 crore, dividend declared

0 0 Wednesday, February 12, 2025 Edit this post

NATCO Pharma reported a 37.75% decline in Q3 FY2025 net profit, dropping to ₹132.4 crore due to a downturn in formulation exports. Consolida...

NATCO Pharma reported a 37.75% decline in Q3 FY2025 net profit, dropping to ₹132.4 crore due to a downturn in formulation exports. Consolidated revenue fell to ₹474.8 crore, with EBITDA down 85.5%, reflecting significant operational challenges.

from mint - markets https://ift.tt/CBZhPMI
via IFTTT